歸創通橋品牌升級:以"爲生命 恆創新"開啓醫療科技新篇章
近日,歸創通橋醫療科技股份有限公司(2190.HK,以下簡稱"歸創通橋"、"公司")宣佈正式啓用新的品牌標語"爲生命 恆創新"。此次品牌煥新不僅體現了歸創通橋戰略與業務的升級,更彰顯了公司對高質量生命的全方位守護,也標誌着伴隨AI時代的來臨,歸創通橋在醫療科技創新道路上邁出了更加堅定的步伐。

當前,人口老齡化、慢性病高發及健康管理需求激增,推動全球醫療健康行業從"被動治療"轉向"主動管理"。歸創通橋成立以來,始終致力於爲全球患者提供高質量且可負擔的創新醫療器械產品和解決方案,讓所有人都能享受先進醫療技術帶來的高質量生活。爲了更好地踐行承諾,歸創通橋從戰略升級、業務拓展、運營變革、品牌強化等多方面,重塑公司的願景與使命。
在全新品牌理念的引領下,歸創通橋致力於打造一個更全面、更智能的醫療生態系統,涵蓋疾病預防、精準診療、術後康復及健康管理等多個環節,助力所有人享受更高質量的生活和生命體驗。同時,歸創通橋將不斷加大在醫療科技領域的投入。隨着AI技術在醫療科技領域展現出的巨大應用潛力,歸創通橋也將積極擁抱AI技術,賦能產品創新與服務升級,推動醫療健康行業邁向更高的效率和智能化水平。
歸創通橋董事長兼CEO趙中博士表示:"此次品牌升級體現了我們對醫療科技未來趨勢的積極佈局。我們將繼續秉承創新基因,與合作夥伴攜手並進,不斷探索醫療科技的前沿領域,爲所有人的高質量生命延續和提升貢獻力量。"
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.